日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Humanized Na(V)1.8 rats overcome cross-species potency shifts in developing novel Na(V)1.8 inhibitors.

人源化 Na(V)1.8 大鼠克服了开发新型 Na(V)1.8 抑制剂时跨物种效力变化的问题

期刊:Neurobiology of Pain
影响因子:3.2
doi:10.1016/j.ynpai.2025.100182
McDevitt Dillon S, Vardigan Joshua D, Zhou Xiaoping, Rosahl Thomas W, Zhou Heather, Price Eric A, Clements Michelle K, Li Yuxing, Varghese Nissi, Krasowska-Zoladek Alicja, Stachel Shawn J, Breslin Michael J, Burgey Christopher S, Kraus Richard L, Pall Parul S, Henze Darrell A, Santarelli Vincent P
其它
Human
Rat
发表日期：2025
文献求助 收藏

Translational Pharmacokinetic-Pharmacodynamic Modeling of NaV1.7 Inhibitor MK-2075 to Inform Human Efficacious Dose

利用转化药代动力学-药效学模型研究NaV1.7抑制剂MK-2075在人体中的有效剂量

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2021.786078
Ballard, Jeanine E; Pall, Parul S; Vardigan, Joshua; Zhao, Fuqiang; Holahan, Marie A; Zhou, Xiaoping; Jochnowitz, Nina; Kraus, Richard L; Klein, Rebecca M; Henze, Darrell A; Houghton, Andrea K; Burgey, Christopher S; Gibson, Christopher; Struyk, Arie
Human
发表日期：2021
文献求助 收藏

Discovery of Arylsulfonamide Na(v)1.7 Inhibitors: IVIVC, MPO Methods, and Optimization of Selectivity Profile

芳基磺酰胺钠(v)1.7抑制剂的发现：体外-体内相关性(IVIVC)、MPO方法及选择性谱的优化

期刊:ACS Medicinal Chemistry Letters
影响因子:4
doi:10.1021/acsmedchemlett.1c00218
Roecker, Anthony J; Layton, Mark E; Pero, Joseph E; Kelly, Michael J 3rd; Greshock, Thomas J; Kraus, Richard L; Li, Yuxing; Klein, Rebecca; Clements, Michelle; Daley, Christopher; Jovanovska, Aneta; Ballard, Jeanine E; Wang, Deping; Zhao, Fuqiang; Brunskill, Andrew P J; Peng, Xuanjia; Wang, Xiu; Sun, Haiyan; Houghton, Andrea K; Burgey, Christopher S
发表日期：2021
文献求助 收藏